PMID- 20561705 OWN - NLM STAT- MEDLINE DCOM- 20101207 LR - 20171116 IS - 1600-0641 (Electronic) IS - 0168-8278 (Linking) VI - 53 IP - 3 DP - 2010 Sep TI - Invading macrophages play a major role in the liver progenitor cell response to chronic liver injury. PG - 500-7 LID - 10.1016/j.jhep.2010.04.010 [doi] AB - BACKGROUND & AIMS: Although a strong association between liver progenitor cells (LPCs) and inflammation exists in many chronic liver diseases, the exact role of the immune system in LPC-mediated hepatic regeneration remains unclear. A number of pro-inflammatory factors were identified in cytokine knockout mice in which the LPC response was attenuated but neither the mechanism nor the producing cells are known. METHODS: To identify the critical immune cells and cytokines required in the LPC response, we compared two diet-induced models of liver injury with two recently established transgenic models of immune-mediated hepatitis. RESULTS: Despite severe inflammation being observed in all models, the generation of LPCs was highly dependent on the cause and kinetics of liver damage. The LPC response was associated with an increase of macrophages and CD8(+) T cells but not natural killer cells. T cell-deficient mice were able to mount a LPC response, albeit delayed, suggesting that T cells are not essential. Mice mounting an LPC response showed elevated numbers of Kupffer cells and invading CX(3)CR1(high)CCR2(high) macrophages secreting persistent high levels of tumour necrosis factor alpha (TNFalpha), a major cytokine involved in the LPC response. CONCLUSIONS: Liver macrophages are an important determinant of LPC expansion during liver regeneration in models of diet- and immune-mediated liver injury. Invading macrophages in particular provide pro-mitogenic cytokines such as TNFalpha that underpin the process. LPC themselves are a source of chemokines (CCL2, CX(3)CL1) that attract infiltrating macrophages. CI - Copyright 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved. FAU - Viebahn, Cornelia S AU - Viebahn CS AD - School of Biomedical, Biomolecular and Chemical Sciences, The University of Western Australia, Australia. connyviebahn@web.de FAU - Benseler, Volker AU - Benseler V FAU - Holz, Lauren E AU - Holz LE FAU - Elsegood, Caryn L AU - Elsegood CL FAU - Vo, Michelle AU - Vo M FAU - Bertolino, Patrick AU - Bertolino P FAU - Ganss, Ruth AU - Ganss R FAU - Yeoh, George C T AU - Yeoh GC LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20100526 PL - Netherlands TA - J Hepatol JT - Journal of hepatology JID - 8503886 RN - 0 (CX3C Chemokine Receptor 1) RN - 0 (Ccr2 protein, mouse) RN - 0 (Cx3cr1 protein, mouse) RN - 0 (RNA, Messenger) RN - 0 (Receptors, CCR2) RN - 0 (Receptors, Chemokine) RN - 0 (Tumor Necrosis Factor-alpha) SB - IM MH - Animals MH - CD8-Positive T-Lymphocytes/immunology/pathology MH - CX3C Chemokine Receptor 1 MH - Chronic Disease MH - Diet/adverse effects MH - Disease Models, Animal MH - Hepatocytes/*pathology MH - Liver Diseases/etiology/genetics/*immunology/*pathology MH - Liver Regeneration/genetics/immunology MH - Macrophages/*immunology/*pathology MH - Mice MH - Mice, Inbred BALB C MH - Mice, Inbred C57BL MH - Mice, Nude MH - Mice, Transgenic MH - RNA, Messenger/genetics/metabolism MH - Receptors, CCR2/metabolism MH - Receptors, Chemokine/metabolism MH - Stem Cells/*pathology MH - Tumor Necrosis Factor-alpha/genetics/metabolism EDAT- 2010/06/22 06:00 MHDA- 2010/12/14 06:00 CRDT- 2010/06/22 06:00 PHST- 2009/11/17 00:00 [received] PHST- 2010/03/02 00:00 [revised] PHST- 2010/04/02 00:00 [accepted] PHST- 2010/06/22 06:00 [entrez] PHST- 2010/06/22 06:00 [pubmed] PHST- 2010/12/14 06:00 [medline] AID - S0168-8278(10)00457-5 [pii] AID - 10.1016/j.jhep.2010.04.010 [doi] PST - ppublish SO - J Hepatol. 2010 Sep;53(3):500-7. doi: 10.1016/j.jhep.2010.04.010. Epub 2010 May 26.